Loomis issues SEK 1,000 million in sustainability-linked bonds
The bonds carry an annual interest rate of 3m Stibor +0.95% and were issued under Loomis'
"Despite a volatile market environment marked by geopolitical tensions, the transaction was well received by the market and attracted strong investor interest, with an order book exceeding
The bonds were issued in accordance with Loomis' Sustainability-Linked Financing Framework, supported by a second-party opinion from Sustainalytics. Loomis has linked the sustainability-linked bonds to a target of reducing the company's absolute carbon emissions by 48% by 2030 compared with 2019 levels.
By continuing to integrate sustainability targets into its financing, Loomis strengthens its sustainability commitments.
Danske Bank and Nordea acted as joint bookrunners.
The bonds will be listed on the regulated market of Euronext Dublin.
In connection with the issuance, Loomis AB offered bondholders the opportunity to participate in partial buybacks of its outstanding bonds maturing in
This press release is also available on Loomis' website, www.loomis.com.
For more information, please contact:
Jenny Boström
Head of Sustainability and IR
[email protected]
+46 79 006 45 92
Fredrik Hammarbäck
Media Relations and External Communications Manager
[email protected]
+46 76 311 56 29
This information was brought to you by Cision http://news.cision.com
The following files are available for download:
Loomis issues |
View original content:https://www.prnewswire.com/news-releases/loomis-issues-sek-1-000-million-in-sustainability-linked-bonds-302798947.html
SOURCE Loomis AB
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Blue Moon Metals Secures Water Pollution Control Permit, Approval of Construction for the Tailings Storage Facility, and Posts Reclamation Bond Allowing Start of Construction at its Springer Tungsten
- MIT and Harvard Graduate Students Unveil New "Navigation Technology" Tools to Bolster Economic Mobility for Economically Disadvantaged Families
- FDA Clearance of C2N Diagnostics' PrecivityAD2 Blood Test Advances Precision Medicine for Alzheimer's, Building on Groundwork Laid by Early ADDF Investment
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share